CRNX

Crinetics Pharmaceuticals, Inc. $84.95 1M +1.3% 3M +156.7% YTD +81.8% as of 2026-09-02
+Watchlist
This price data has stopped updating. The last bar is 2026-09-02, 12 days ago — our data source no longer publishes CRNX. Everything below is as of that date, not today.

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.3%
Next 1 week
-1.0%
Next 1 month
-0.2%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply overbought — RSI(2) at 94
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.83%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.49 -0.1% · Seasonal tilt (7y) -0.1%
$193M/day volume 112% volatility +155% 1-year -0% from ATH
52-week range · 100% of the way up · -0% from the high
$31.00$85.01

Congressional trades in CRNX Full tracker →

2 members · 4 buys / 2 sells · $20K–$125K disclosed · latest filing Sep 4, 2026.

SELL GC Gilbert Cisneros · traded Jul 30, 2026 $15K–$50K
BUY GC Gilbert Cisneros · traded Mar 3, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Apr 17, 2025 $1K–$15K
SELL JG Josh Gottheimer · traded Mar 19, 2025 $1K–$15K
BUY GC Gilbert Cisneros · traded Jan 29, 2025 $1K–$15K
BUY JG Josh Gottheimer · traded Sep 25, 2024 $1K–$15K

Earnings Full history →

Next report 2026-11-05 (Thursday, after close, in 52 days) · EPS est. -1.06.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.